Clinical Research Associate
Translational Research in Oncology
Clinical Research Associate
Translational Research in Oncology
Translational cancer research in clinical trials
Prior to applying please review TRIO's Applicant Information Notice
To support efficiency, TRIO may use limited AI tools during the candidate review process. All hiring decisions are made by people, not AI.
To ensure fairness and an accurate understanding of your skills, we ask that candidates refrain from using AI tools or AI‑generated responses during interviews or assessments. We want the opportunity to get to know you and your experience.
Teamwork · Passion · Integrity · Innovation
Translational cancer research in clinical trials
TRIO is an academic clinical research organization focused on translating cancer science into patient treatments. It coordinates translational cancer research by bringing innovative, targeted therapeutic ideas into clinical trials. The group operates through an international network, with offices in Canada, France, and Uruguay and partnerships with about 2,000 investigators and 450 cancer centers in more than 45 countries, allowing global studies of systemic cancer therapies. Compared with typical biotech or pharma firms, TRIO emphasizes academic collaboration and real-world trial execution across many centers rather than developing and selling drugs itself. Its goal is to move promising cancer treatments from the lab to the clinic, testing them in trials to improve outcomes for patients.
Explore more opportunities at Translational Research in Oncology